Growth/differentiation factor 15 (GDF15) expression in the heart after myocardial infarction and cardioprotective effect of pre-ischemic rGDF15 administration

被引:7
作者
Dogon, Geoffrey [1 ]
Rigal, Eve [1 ]
Potel, Eliot [1 ]
Josse, Marie [1 ]
Rochette, Luc [1 ]
Bejot, Yannick [1 ,2 ]
Vergely, Catherine [1 ]
机构
[1] Univ Burgundy, Fac Hlth Sci, Res Team Physiopathol & Epidemiol Cerebro Cardiova, 7 Bd Jeanne Arc, F-21000 Dijon, France
[2] Dijon Univ Hosp, Dept Neurol, Dijon, France
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
关键词
GDF-15; Ischemia-reperfusion injury; Heart; Preconditioning; Cardioprotection; GROWTH-DIFFERENTIATION FACTOR-15; ISCHEMIA/REPERFUSION INJURY; ISCHEMIA-REPERFUSION; RECEPTOR; PATHWAY; BETA; MORTALITY; INSIGHTS; EVENTS; STRESS;
D O I
10.1038/s41598-024-63880-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Growth/differentiation factor-15 (GDF15) is considered an unfavourable prognostic biomarker for cardiovascular disease in clinical data, while experimental studies suggest it has cardioprotective potential. This study focuses on the direct cardiac effects of GDF15 during ischemia-reperfusion injury in Wistar male rats, employing concentrations relevant to patients at high cardiovascular risk. Initially, we examined circulating levels and heart tissue expression of GDF15 in rats subjected to ischemia-reperfusion and sham operations in vivo. We then evaluated the cardiac effects of GDF15 both in vivo and ex vivo, administering recombinant GDF15 either before 30 min of ischemia (preconditioning) or at the onset of reperfusion (postconditioning). We compared infarct size and cardiac contractile recovery between control and rGDF15-treated rats. Contrary to our expectations, ischemia-reperfusion did not increase GDF15 plasma levels compared to sham-operated rats. However, cardiac protein and mRNA expression increased in the infarcted zone of the ischemic heart after 24 h of reperfusion. Notably, preconditioning with rGDF15 had a cardioprotective effect, reducing infarct size both in vivo (65 +/- 5% in control vs. 42 +/- 6% in rGDF15 groups) and ex vivo (60 +/- 4% in control vs. 45 +/- 4% in rGDF15 groups), while enhancing cardiac contractile recovery ex vivo. However, postconditioning with rGDF15 did not alter infarct size or the recovery of contractile parameters in vivo or ex vivo. These novel findings reveal that the short-term exogenous administration of rGDF15 before ischemia, at physiologically relevant levels, protects the heart against ischemia-reperfusion injury in both in vivo and ex vivo settings. The ex vivo results indicate that rGDF15 operates independently of the inflammatory, endocrine and nervous systems, suggesting direct and potent cardioprotective properties against ischemia-reperfusion injury.
引用
收藏
页数:14
相关论文
共 42 条
[21]   Interdependent roles for growth differentiation factor-15 (GDF15) and LIMS1 in regulating cell migration: Implications for colorectal cancer metastasis [J].
Kotsoni, Andria ;
Kozaki, Louiza Valentina ;
Stylianou, Andreas ;
Gkretsi, Vasiliki .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2025, 1872 (03)
[22]   GDF-15 (Growth Differentiation Factor 15) Is Associated With Lack of Ventricular Recovery and Mortality After Transcatheter Aortic Valve Replacement [J].
Kim, Juyong Brian ;
Kobayashi, Yukari ;
Moneghetti, Kegan J. ;
Brenner, Daniel A. ;
O'Malley, Ryan ;
Schnittger, Ingela ;
Wu, Joseph C. ;
Murtagh, Gillian ;
Beshiri, Agim ;
Fischbein, Michael ;
Miller, D. Craig ;
Liang, David ;
Yeung, Alan C. ;
Haddad, Francois ;
Fearon, William F. .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (12)
[23]   Growth differentiation factor 15 (GDF15)-mediated HER2 phosphorylation reduces trastuzumab sensitivity of HER2-overexpressing breast cancer cells [J].
Joshi, Jayashree P. ;
Brown, Nicole E. ;
Griner, Samantha E. ;
Nahta, Rita .
BIOCHEMICAL PHARMACOLOGY, 2011, 82 (09) :1090-1099
[24]   Growth Differentiation Factor 15: A Prognostic Marker in Patients with Acute Chest Pain without Acute Myocardial Infarction [J].
Myrmel, Gard M. S. ;
Steiro, Ole-Thomas ;
Tjora, Hilde L. ;
Langorgen, Jorund ;
Bjorneklett, Rune ;
Skadberg, Oyvind ;
Bonarjee, Vernon V. S. ;
Mjelva, oistein R. ;
Pedersen, Eva K. R. ;
Vikenes, Kjell ;
Omland, Torbjorn ;
Aakre, Kristin M. .
CLINICAL CHEMISTRY, 2023, 69 (06) :649-660
[25]   Growth differentiation factor-15 and all-cause mortality in patients with suspected myocardial infarction [J].
Walter, Joan ;
Nestelberger, Thomas ;
Boeddinghaus, Jasper ;
Twerenbold, Raphael ;
Croton, Lukas ;
Badertscher, Patrick ;
Wildi, Karin ;
Wussler, Desiree ;
de Lavallaz, Jeanne du Fay ;
Mueller, Christian ;
Gimenez, Maria Rubini ;
Puelacher, Christian ;
Kozhuharov, Nikola ;
Morawiec, Beata ;
Rentsch, Katharina ;
Miro, Oscar ;
Martin-Sanchez, F. Javier ;
Muzyk, Piotr ;
Geigy, Nicolas ;
Keller, Dagmar I. ;
Reichlin, Tobias ;
Lohrmann, Jens ;
Biskup, Ewalina ;
Kloos, Wanda ;
Lopez, Beatriz ;
Fuenzalida Inostroza, Carolina ;
Rodriguez Adrada, Esther ;
Kawecki, Damian ;
Muzyk, Piotr ;
Nowalany-Kozielska, Ewa ;
Parenica, Jiri ;
Meissner, Kathrin ;
Kulangara, Caroline ;
Mahfouz, Riham ;
Rentsch, Katharina ;
von Eckardstein, Arnold .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 292 :241-245
[26]   Relation of Growth-Differentiation Factor 15 to Left Ventricular Remodeling in ST-Segment Elevation Myocardial Infarction [J].
Dominguez-Rodriguez, Alberto ;
Abreu-Gonzalez, Pedro ;
Avanzas, Pablo .
AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (07) :955-958
[27]   Growth Differentiation Factor 15 as a Predictor of the No-Reflow Phenomenon in Patients with ST-Segment Elevation Myocardial Infarction [J].
Kozuch, Marcin ;
Poludniewski, Maciej ;
Dabrowski, Emil Julian ;
Tarasiuk, Ewa ;
Dobrzycki, Slawomir .
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
[28]   Growth differentiation factor-15 as a biomarker of coronary microvascular dysfunction in ST-segment elevation myocardial infarction [J].
Tian, Rui ;
Wang, Zerui ;
Zhang, Shenglin ;
Wang, Xiaojun ;
Zhang, Yiwen ;
Yuan, Jiaquan ;
Zhang, Jiajun ;
Xu, Feng ;
Chen, Yuguo ;
Li, Chuanbao .
HELIYON, 2024, 10 (15)
[29]   Growth differentiation factor-15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program [J].
Ferreira, Joao Pedro ;
Packer, Milton ;
Butler, Javed ;
Filippatos, Gerasimos ;
Pocock, Stuart J. ;
Januzzi, James L. ;
Sattar, Naveed ;
Maldonado, Sandra Gonzalez ;
Panova-Noeva, Marina ;
Sumin, Mikhail ;
Masson, Serge ;
Anker, Stefan D. ;
Zannad, Faiez .
EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (01) :155-164
[30]   Cardioprotective Effect of Growth Differentiation Factor 15 Against Isoproterenol-Induced Cardiomyocyte Apoptosis via Regulation of the Mitochondrial Fusion [J].
Zhang, Yan ;
Mei, Zhu ;
Jia, Xiaodong ;
Song, Haixu ;
Liu, Jing ;
Tian, Xiaoxiang .
CARDIOLOGY DISCOVERY, 2022, 2 (02) :89-96